Early research (Phase 1)Ended earlyNCT05673109
What this trial is testing
AC176 for the Treatment of Metastatic Castration Resistant Prostate Cancer
Who this might be right for
Metastatic Castration Resistant Prostate Cancer
Accutar Biotechnology Inc 8